CR6086-1-04 Study Portal - [DEV]

AN OPEN-LABEL, SINGLE-ARM, PHASE IB/IIA TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF THE EP4 RECEPTOR ANTAGONIST CR6086 IN COMBINATION WITH THE PD-1 INHIBITOR BALSTILIMAB (AGEN2034), IN PATIENTS WITH PRETREATED MISMATCH-REPAIR-PROFICIENT AND MICROSATELLITE STABLE METASTATIC COLORECTAL CANCER, AND OTHER METASTATIC GI CANCERS

Password Recovery Page

Type your username and click the button in order to obtain your password:

(an email will be sent to the address provided to the Study Team at the beginning of the Trial)

Back to login page